Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Micro-He Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Micro-He Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Micro-He Biotechnology
Manufacturer of synthetic biology products intended for sustainable production purposes. The company offers on constructing efficient cell factories through microbial metabolic pathway regulation, incorporating industrial strain development, fermentation process optimization, and scalable biomanufacturing capabilities, enabling the functional food and nutrition markets to access high-quality, traceable raw materials with improved consistency, reduced environmental impact, and enhanced adaptability for diverse applications in health-oriented industries.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Micro-He Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Micro-He Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Micro-He Biotechnology in its N-PORT filings yet. We sweep new filings monthly.